Valuation: Dr. Martens plc

Market Cap 65Cr 86Cr 75Cr 71Cr 121Cr 8.21TCr 121.94Cr 851Cr 329.77Cr 4.18TCr 321.11Cr 314.14Cr 14TCr P/E 2027 *
13.7x
P/E 2028 * 11x
Enterprise Value 84Cr 111.52Cr 98Cr 92Cr 157.78Cr 11TCr 159.01Cr 1.11TCr 430.01Cr 5.45TCr 418.72Cr 409.63Cr 18TCr EV / Sales 2027 *
1.08x
EV / Sales 2028 * 0.99x
Free-Float
57.57%
Yield 2027 *
3.7%
Yield 2028 * 3.75%
1 week+1.94%
Current month-11.24%
1 month-16.84%
3 months-1.86%
6 months+9.72%
Current year-7.60%
1 week 0.75
Extreme 0.75
0.8
1 month 0.74
Extreme 0.74
0.96
3 years 0.52
Extreme 0.52
1.68
5 years 0.52
Extreme 0.52
5.12
Manager TitleAgeSince
Chief Executive Officer 55 06/01/2025
Director of Finance/CFO 53 13/05/2024
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 01/01/2021
Director/Board Member 55 10/07/2025
Director/Board Member 52 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+1.94%-24.76%-53.53% 86Cr
+0.11%-1.29%-29.26%-7.54% 1.07TCr
+4.14%+6.95%-37.38%-34.18% 593.86Cr
-0.95%+0.36%+59.30%+42.79% 591.83Cr
+1.18%+1.99%-29.89% - 565.51Cr
-0.24%+3.30%-1.65%+35.83% 256.72Cr
+0.20%+0.60%-13.37%-13.67% 230.89Cr
+0.99%-0.21%-31.92%+133.66% 158.39Cr
+0.45%+3.90%+37.64%+65.75% 153.68Cr
-1.35%-0.68%-34.30% - 115.15Cr
Average +0.50%+0.70%-10.56%+21.14% 415.28Cr
Weighted average by Cap. +0.74%+0.91%-11.56%+9.45%

Financials

2027 *2028 *
Net sales 78Cr 103.58Cr 91Cr 86Cr 146.55Cr 9.94TCr 147.69Cr 1.03TCr 399.41Cr 5.06TCr 388.91Cr 380.47Cr 16TCr 82Cr 108.63Cr 96Cr 90Cr 153.69Cr 10TCr 154.89Cr 1.08TCr 418.87Cr 5.31TCr 407.87Cr 399.01Cr 17TCr
Net income 4.85Cr 6.42Cr 5.64Cr 5.32Cr 9.08Cr 615.82Cr 9.15Cr 64Cr 25Cr 313.42Cr 24Cr 24Cr 1.02TCr 6.02Cr 7.95Cr 7Cr 6.6Cr 11Cr 763.54Cr 11Cr 79Cr 31Cr 388.6Cr 30Cr 29Cr 1.26TCr
Net Debt 20Cr 26Cr 23Cr 22Cr 37Cr 2.5TCr 37Cr 258.68Cr 100.24Cr 1.27TCr 98Cr 95Cr 4.13TCr 16Cr 22Cr 19Cr 18Cr 31Cr 2.09TCr 31Cr 216.97Cr 84Cr 1.07TCr 82Cr 80Cr 3.47TCr
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
-
Date Price Change
25/26/25 €0.7900 0.00%
24/26/24 €0.7900 +1.94%
23/26/23 €0.7750 -0.64%
22/26/22 €0.7800 -2.50%
21/26/21 €0.8000 +2.56%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6760GBP
Average target price
0.9850GBP
Spread / Average Target
+45.71%

Quarterly revenue - Rate of surprise